Enterome
0 followers
Enterome’s OncoMimic technology allows the overcoming of immune tolerance against cancer cells, with broad applicability against solid tumor via an off-the-shelf, easy to manufacture technology. Enterome’s potentially first-in-class small protein and peptide drug candidates modulate the immune syste... Read more
Org chart
Belichard Pierre
Collapse
Anne Dagallier
Chief Business Officer
Christelle Dumoussaud
Chief Financial Officer
Guillaume Bayre
Head of Communications
Jan Fagerberg
Chief Medical Officer
Jean-Michel Paillarse
Chief Medical Officer
Joel Richard, PhD, HDR
Chief Development Officer
Marie-Laure Bouttier
Chief Corporate Officer
Pierre Sahakian
Head Of Regulatory Affairs
Joao G. Magalhaes
Head of Immunology research
